Press Releases

Calyx Supports over 100 COVID-19 Vaccine Authorizations

Calyx RIM publishing module relied on for critical submissions of coronavirus vaccine trial data to global regulatory bodies.

ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford

ENPICOM, an innovative bioinformatics software engineering company, has announced the upcoming expansion of the IGX Platform’s capabilities towards advanced liability prediction.

Formedix and CDISC Join Forces to Provide Free Access to Ready-to-Use, CDASH-Compliant eCRFs for Accelerated Clinical Trial Set-Up

Formedix announces today a collaboration with CDISC, the global clinical research data standards development organization, to create a novel portal providing free access to ready-to-use, CDASH-compliant, annotated electronic case report forms (eCRFs) – which I thought would be of interest to you and your readers.

Sygnature Discovery expands into early CMC development

Sygnature Discovery, a leading Drug Discovery Contract Research Organisation, has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. The new service line, located at its headquarters in Nottingham, UK, will expand on the company’s offerings to customers by bridging into formal preclinical drug development and paving the way for clinical trials.

Celemics Partner with Strand Life Science and their StrandOmics Analysis Platform

Dear Nicole, Celemics, a Korea-based biomaterial technology leader that has developed a range of innovative biomaterials and sequencing methods used in the medical, pharmaceutical, microbiome, synthetic biology, and breeding fields, has announced a partnership with Strand Life Sciences, a leading precision medicine informatics company.

Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization Medtech Services Company

Veranex today announced the formation of the first concept-to-commercialization global service provider dedicated to the medtech industry. As the first phase in building this global entity, Veranex has acquired three complementary solution providers: Ximedica, Quartesian, and Boston Healthcare Associates.

Perlara partners with Vivan Therapeutics to tackle rare genetic diseases

Today, Perlara PBC, a rare disease public benefit company, has announced a collaboration with Vivan Therapeutics, developers of personalised therapeutics, to identify novel therapeutics for rare genetic diseases.

Andaman7 offers step change for digital health in Africa

Clinion Launches CSR Automation to Improve the Speed and Efficiency of Clinical Study Reporting

Clinion today announced the launch of a new version of its CSR Automation Tool - a comprehensive AI and Automation technology solution that enables rapid, independent automated generation of a Clinical Study Report (CSR). Contract research organizations (CROs) and Sponsors can take advantage of this AI enabled automation platform which offers:

BEKHealth Secures $4 Million in Funding to Expand Availability and Adoption of its AI-Powered Clinical Research Software Platform

BEKHealth today announced $4 million in funding to accelerate the adoption of the company’s clinical research software platform. BEKHealth’s AI-powered platform accelerates and improves clinical research processes by combining electronic medical record (EMR) data processing, feasibility and site selection, precision patient trial matching, and care coordination.

MicrobioSeq Introduces Skin Microbiome Solutions to Accelerate Research and Practice

Enveda Biosciences Closes $51M Series A Financing Led by Lux Capital

Enveda Biosciences raises $51M Series A Financing Led by Lux Capital. This funding will advance Enveda’s platform to discover and develop new drug candidates from the first high-resolution chemical map of the natural world.

Avania Acquires IMARC, Global Medical Device CRO

Avania, a leading global medical technology CRO, today announced its acquisition of IMARC, a highly respected medical device CRO headquartered in Strongsville, Ohio and providing service throughout the United States. IMARC brings more than two decades of full-service clinical research oversight to its clients, including monitoring, auditing, safety, data management, and training.

AMRI Celebrates 30th Anniversary

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, celebrates 30 years since its incorporation in Albany, New York.

Dolomite Bio’s distributor list expands globally

Dolomite Bio, a company that creates innovative products for high throughput single cell research, has announced the expansion of their current list of distributors.

Jubilant Biosys and Yale University have announced a research collaboration for multiple programs

Jubilant Biosys will provide research services to investigators at Yale University working on novel therapeutic targets.

Alfa Chemistry Diversifies Supply of Active Pharmaceutical Ingredients for Pharmaceutical Preparation

Protheragen MedAI Offers Comprehensive Solutions for Drug Research and Development, Medical Imaging and Medical Therapy and Research System

PolyNovo’s NovoSorb® BTM technology featured in a new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions

PolyNovo, developers of innovative medical devices, has announced that its NovoSorb® BTM technology has been featured in a new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions.

Bio-Gate and Avicanna complete first phase of development on CBD and Micro Silver BG™ based skin care products for global commercialization

About Bio-Gate: Bio-Gate AG is one of the world’s leading providers of innovative technologies and customised solutions for health and hygiene. Our aim is to make living together safer and healthier and to improve the well-being of all individuals. Bio-Gate enhances materials and products with its technologies and antimicrobial and antiviral strategies, and, thereby improves the quality of life of people and animals alike. The company specializes in equipping materials and surfaces with antiviral and antimicrobial properties. Bio-Gate AG enhances materials and products, particularly in the field of medical technology, such as the coating of implants or wound dressings. In addition, Bio-Gate technologies are used to provide consumer, industrial and hygiene products, such as paints, coatings, plastics or protective film sprays with antiviral and antimicrobial properties, thus enhancing them in a unique way. Bio-Gate also uses its unique and multi-functional additive MicroSilver BG in dermatology and cosmetics as well as wound care to provide these kind of products with long-lasting antimicrobial, anti-inflammatory and Microbiome friendly properties.